Apr 20, 2023 / 12:00PM GMT
Operator
Ladies and gentlemen, welcome to the Hansa Biopharma Q1 2023 Conference Call. My name is Grant, and I'll be the moderator for today's call. (Operator Instructions) I will now hand you over to your host, Søren Tulstrup, CEO of Handset Biopharma to begin. Please go ahead.
Søren Tulstrup - Hansa Biopharma AB(publ)-President&CEO
Thank you, moderator. Good afternoon, good morning, and welcome to the Hansa Biopharma Conference Call to review first quarter 2023 results. I'm Søren Tulstrup, CEO of Hansa Biopharma. Joining me today is our CFO, Donato Spotd; and Hansen's Head of Investor Relations, Klaus Sindahl. Today, we'll discuss the progress we made during the first quarter of 2023 and review our near-term milestones. The presentation should take roughly 15 minutes, after which there will be an opportunity to ask questions during a Q&A session. Now please turn to Slide 2.
Please allow me to draw your attention to the fact that we'll be making forward-looking statements during this
Q1 2023 Hansa Biopharma AB Earnings Call Transcript
Apr 20, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers